|
Oct 3
|
Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor Events
|
|
Sep 17
|
Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER Trial
|
|
Jul 24
|
Quest Diagnostics' (DGX) Haystack Oncology Forges New MRD Deal
|
|
Jun 13
|
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
|
|
Jan 4
|
Lisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care Therapy
|
|
Nov 28
|
Lisata Therapeutics to Present at NobleCon19 Investor Conference
|
|
Nov 9
|
Lisata Therapeutics Announces Participation in Upcoming Conferences in November
|
|
Nov 7
|
All You Need to Know About Lisata Therapeutics, Inc. (LSTA) Rating Upgrade to Buy
|
|
Nov 5
|
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Q3 2023 Lisata Therapeutics Inc Earnings Call
|
|
Nov 2
|
Lisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
|
|
Sep 28
|
Lisata Therapeutics Announces Participation in Upcoming Conferences in October
|
|
Aug 19
|
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q2 2023 Earnings Call Transcript
|
|
Aug 16
|
Q2 2023 Lisata Therapeutics Inc Earnings Call
|